Send to

Choose Destination
See comment in PubMed Commons below
Oxid Med Cell Longev. 2013;2013:796891. doi: 10.1155/2013/796891. Epub 2013 Apr 30.

Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease.

Author information

  • 1Second Department of Internal Medicine, Kansai Medical University, Moriguchi City 570-8507, Japan.

Erratum in

  • Oxid Med Cell Longev. 2013;2013:936436.


Oxidative stress has been implicated in pathophysiology of aging and age-associated disease. Antioxidative medicine has become a practice for prevention of atherosclerosis. However, limited success in preventing cardiovascular disease (CVD) in individuals with atherosclerosis using general antioxidants has prompted us to develop a novel antioxidative strategy to prevent atherosclerosis. Reducing visceral adipose tissue by calorie restriction (CR) and regular endurance exercise represents a causative therapy for ameliorating oxidative stress. Some of the recently emerging drugs used for the treatment of CVD may be assigned as site-specific antioxidants. CR and exercise mimetic agents are the choice for individuals who are difficult to continue CR and exercise. Better understanding of molecular and cellular biology of redox signaling will pave the way for more effective antioxidative medicine for prevention of CVD and prolongation of healthy life span.

[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Write to the Help Desk